Evidence map›Paper›PMID 34943457›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.

Chung-Chieh Chiao, Yen-Hsi Liu, Nam Nhut Phan, Nu Thuy An Ton, Hoang Dang Khoa Ta, Gangga Anuraga, Do Thi Minh Xuan, Fenny Fitriani, Elvira Mustikawati Putri Hermanto, Muhammad Athoillah and 7 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Chung-Chieh ChiaoPh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science, Taipei Medical University, Taipei 11031, Taiwan.
Yen-Hsi LiuGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Nam Nhut PhanNTT Institute of Hi-Technology, Nguyen Tat Thanh University, Ho Chi Minh City 700000, Vietnam.
Nu Thuy An TonNTT Institute of Hi-Technology, Nguyen Tat Thanh University, Ho Chi Minh City 700000, Vietnam.
Hoang Dang Khoa TaPh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-8809-239X
Gangga AnuragaPh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-0902-3968
Do Thi Minh XuanGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Fenny FitrianiDepartment of Statistics, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya 60234, Indonesia.ORCID 0000-0001-9548-261X
Elvira Mustikawati Putri HermantoDepartment of Statistics, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya 60234, Indonesia.
Muhammad AthoillahDepartment of Statistics, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya 60234, Indonesia.ORCID 0000-0002-1800-1314
Vivin AndrianiDepartment of Biological Science, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya 60234, Indonesia.
Purity Sabila AjiningrumDepartment of Biological Science, Faculty of Science and Technology, Universitas PGRI Adi Buana, Surabaya 60234, Indonesia.
Yung-Fu WuDepartment of Medical Research, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei 11490, Taiwan.
Kuen-Haur LeePh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-6354-3315
Jian-Ying ChuangTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-5124-0643
Chih-Yang WangPh.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-4137-5074
Tzu-Jen KaoTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Taipei Medical University · TWUniversitas PGRI Semarang · IDTrường ĐH Nguyễn Tất Thành · VNTri-Service General Hospital · TWWan Fang Hospital · TW

Funding

Ministry of Science and Technology (MOST) of Taiwan MOST 110-2320-B-038-017-MY3
6 · The paper itself

Abstract

The complexity of breast cancer includes many interacting biological processes, and proteasome alpha (PSMA) subunits are reported to be involved in many cancerous diseases, although the transcriptomic expression of this gene family in breast cancer still needs to be more thoroughly investigated. Consequently, we used a holistic bioinformatics approach to study the

Indexed as

bioinformaticsbreast cancerPSMA family genes

Identifiers

PMID34943457
PMCPMC8699889
OpenAlexW3216387334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.